Abstract P2089: Heavy coffee consumption is associated with borderline high risk of coronary heart disease - a meta-analysis

Background: Coffee's global popularity arises from its stimulating effects on the central nervous system, taste, and aroma, making it one of the most widely consumed beverages. Numerous studies have explored the potential link between coffee consumption and diseases, particularly coronary heart disease (CHD), yet this association remains debatable. Purpose: This study aims to assess the risks and benefits of coffee consumption concerning CHD, compared to individuals who do not drink coffee. Methods: An umbrella meta-analysis incorporating existing meta-analyses was conducted. A systematic search was performed on the PubMed database from 2006 to 2023 using the PRISMA protocol. MeSH terms "coffee consumption," "coronary artery disease," and "myocardial infarction" were used. The study included 3.28 million participants from cohort studies across four prospective meta-analyses. Additionally, subgroup analysis based on varying levels of coffee intake (very-heavy, moderate, and light) was performed. Analysis was conducted using RevMan to derive a summarised risk ratio (RR) of CHD/MI associated with coffee consumption and a 95% Confidence Interval. Risk bias was incorporated using RoBANS integrated with RevMan. Sensitivity analysis was conducted by excluding one study at a time to derive Heterogeneity Index (I 2 ) scores. Forest plots were generated, with statistical significance set at p<0.05. Results: The study comprised four meta-analyses meeting the inclusion criteria, incorporating 80 studies involving 3.28 million individuals worldwide. Compared to non-coffee drinkers, coffee consumers had a summarized risk ratio of 1.08 (95%CI: 1.01-1.14, I2: 76%, p<0.00001). Subgroup analysis, with one study omitted, revealed that very-heavy coffee drinkers had a risk ratio of 1.14 (0.99-1.29, 73%, p<0.00001), moderate coffee drinkers had a risk ratio of 1.02 (0.89-1.14, 77%, p<0.00001), and light coffee drinkers had a risk ratio of 1.00 (0.94-1.06, 0%, p<0.00001). Conclusion: Based on our umbrella meta-analysis, very-heavy coffee consumption is associated with a borderline increased risk of CHD. However, no significant difference was found between moderate and light coffee drinkers regarding CHD risk.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-03-11
DOI
https://doi.org/10.1161/cir.151.suppl_1.p2089
Primary Topic
Coffee research and impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract P2089: Heavy coffee consumption is associated with borderline high risk of coronary heart disease - a meta-analysis

Athmananda Nanjundappa, Tarun Parvataneni, Rishabh Kumar Rana, Sakshi Jain et al.
Circulation
Coffee research and impacts
article

Abstract P2089: Heavy coffee consumption is associated with borderline high risk of coronary heart disease - a meta-analysis

Athmananda Nanjundappa, Tarun Parvataneni, Rishabh Kumar Rana, Sakshi Jain, Chandu Siripuram, Neel Patel, Nitish Naik, Urvish Patel, Harmeet Gill, Lovekumar Vala, Shika M Jain, Rashi Bharat Patel, Vaishnavi Sirekulam, Tanzina Khan, Sudharani Kintada
article en

Abstract

Background: Coffee's global popularity arises from its stimulating effects on the central nervous system, taste, and aroma, making it one of the most widely consumed beverages. Numerous studies have explored the potential link between coffee consumption and diseases, particularly coronary heart disease (CHD), yet this association remains debatable. Purpose: This study aims to assess the risks and benefits of coffee consumption concerning CHD, compared to individuals who do not drink coffee. Methods: An umbrella meta-analysis incorporating existing meta-analyses was conducted. A systematic search was performed on the PubMed database from 2006 to 2023 using the PRISMA protocol. MeSH terms "coffee consumption," "coronary artery disease," and "myocardial infarction" were used. The study included 3.28 million participants from cohort studies across four prospective meta-analyses. Additionally, subgroup analysis based on varying levels of coffee intake (very-heavy, moderate, and light) was performed. Analysis was conducted using RevMan to derive a summarised risk ratio (RR) of CHD/MI associated with coffee consumption and a 95% Confidence Interval. Risk bias was incorporated using RoBANS integrated with RevMan. Sensitivity analysis was conducted by excluding one study at a time to derive Heterogeneity Index (I 2 ) scores. Forest plots were generated, with statistical significance set at p<0.05. Results: The study comprised four meta-analyses meeting the inclusion criteria, incorporating 80 studies involving 3.28 million individuals worldwide. Compared to non-coffee drinkers, coffee consumers had a summarized risk ratio of 1.08 (95%CI: 1.01-1.14, I2: 76%, p<0.00001). Subgroup analysis, with one study omitted, revealed that very-heavy coffee drinkers had a risk ratio of 1.14 (0.99-1.29, 73%, p<0.00001), moderate coffee drinkers had a risk ratio of 1.02 (0.89-1.14, 77%, p<0.00001), and light coffee drinkers had a risk ratio of 1.00 (0.94-1.06, 0%, p<0.00001). Conclusion: Based on our umbrella meta-analysis, very-heavy coffee consumption is associated with a borderline increased risk of CHD. However, no significant difference was found between moderate and light coffee drinkers regarding CHD risk.

CirculationVol. 151(Suppl_1)
Hackensack University Medical Center (US), Navsari Agricultural University (IN), MedStar Franklin Square Medical Center (US), Ballari Medical College and Research Centre (IN), Community Medical Center (US), Rangaraya Medical College (IN), Anugrah Narayan Magadh Medical College & Hospital (IN), MVJ Medical College and Research Hospital (IN), Regional Medical Center (US), University of South Carolina Aiken (US), Dhaka Medical College and Hospital (BD), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 91%
Coffee research and impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.